Breast Cancer Biomarkers: Risk Assessment, Diagnosis, Prognosis, Prediction of Treatment Efficacy and Toxicity, and Recurrence

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|30|4879-4898

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.30, 2014-09, pp. : 4879-4898

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarkers for Risk Assessment and Prevention of Breast Cancer

By  

Current Cancer Drug Targets, Vol. 9, Iss. 4, 2009-06 ,pp. : 482-499

Bentham Science Publishers

Access to resources Recommend Favorite

Benefit-Risk Assessment of Bevacizumab in the Treatment of Breast Cancer

By Dienstmann Rodrigo  

Drug Safety, Vol. 35, Iss. 1, 2012-01 ,pp. : 15-25

Adis International

Access to resources Recommend Favorite

Genomics-Based Prognosis and Therapeutic Prediction in Breast Cancer

By Jeffrey Stefanie S.   Lønning Per Eystein   Hillner Bruce E.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 3, 2005-05 ,pp. : 291-300

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Expression biomarkers for clinical efficacy and outcome prediction in cancer

By Strand Kathryn J   Khalak Hanif   Strovel Jeffrey W   Ebner Reinhard   Augustus Meena  

Pharmacogenomics, Vol. 7, Iss. 1, 2006-01 ,pp. : 105-115

Future Medicine

Access to resources Recommend Favorite

PET in Cervical Cancer — Implications for 'Staging,' Treatment Planning, Assessment of Prognosis, and Prediction of Response

By Gold Michael A.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 1, 2008-01 ,pp. : 37-45

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite